Zymergen, Inc.

General Information
Business:

(Zymergen says in the prospectus: “In connection with our initial public offering, we plan to convert to a public benefit corporation incorporated in Delaware as a demonstration of our long-term commitment to our mission to displace the petrochemicals that pollute the Planet by designing, developing, and commercializing bio-based materials that deliver better performance than existing products, at attractive costs.”)

We partner with Nature to design, develop, and commercialize bio-based breakthrough products that deliver extraordinary value to customers in a broad range of industries. Our first innovations include films designed for electronics companies to use in new categories of smart devices, including rollable tablets and naturally derived UV protection. Our consumer products include ZYM0201, a naturally derived non-DEET insect repellent, and we plan on partnering to create a microbial alternative to synthetic nitrogen fertilizer. We call our process biofacturing and we expect it will create better products faster, cheaper and more sustainably than traditional chemistry by engineering microbes to make novel biomolecules that are the key ingredients in those products. Our goal is to launch our products in about half the time and 1/10th of the cost (about five years and $50 million per product) of what traditional chemicals and materials companies can deliver, which would allow us to address a wide array of commercial applications.

(Note: Zymergen, Inc. upsized its IPO at pricing on April 21, 2021, to 16.3 million shares, up from 13.6 million in the prospectus,  at $31 – the top of its $28-to-$31 price range – to raise $505.3 million.) 

Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Employees: 762
Founded: 2013
Contact Information
Address 5980 Horton Street, Suite 105 Emeryville CA 94608
Phone Number (415) 801-8073
Web Address http://www.zymergen.com/
View Prospectus: Zymergen, Inc.
Financial Information
Market Cap $3041.41mil
Revenues $13.28 mil (last 12 months)
Net Income $-262.19 mil (last 12 months)
IPO Profile
Symbol ZY
Exchange NASDAQ
Shares (millions): 16.3
Price range $31.00 - $31.00
Est. $ Volume $505.3 mil
Manager / Joint Managers J.P. Morgan/ Goldman Sachs/ BofA Securities/ Cowen/ UBS Investment Bank/ Lazard
CO-Managers -
Expected To Trade: 4/22/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change